MRI offers a unique opportunity for theranostic agent development. By engineering both polymer and peptide materials, we have scope to successfully target, image and treat a range of biological conditions. Here we successfully demonstrate the use of targeted and triggered nanoparticles, encapsulating imaging and chemotherapeutic agents, as theranostics for MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords